Mylan announced the launch of Prednisolone Sodium Phosphate Orally Disintegrating Tablets, the generic of Shionogi’s Orapred ODT.

Orapred ODT acts as an anti-inflammatory or immunosuppressive agent for some conditions, and is also indicated for various endocrine conditions, and for palliation of certain neoplastic conditions. Prednisolone is a synthetic adrenocortical steroid with predominantly glucocorticoid properties. Some pharmacological effects include: promotion of gluconeogenesis, increased deposition of glycogen in the liver, inhibition of utilization of glucose, anti-insulin activity, increased catabolism of protein, increased lipolysis, and others.

RELATED: For Some Children, Prednisolone May Protect from Recurrent Wheezing

Prednisolone Sodium Phosphate Orally Disintegrating Tablets is available in 10mg, 15mg, and 30mg, strengths.

Continue Reading

For more information call (800) RX-MYLAN or visit